Leopold Achengui Zekeng

Title: Leopold Achengui Zekeng: Innovator in Retroviral Research

Introduction

Leopold Achengui Zekeng is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunodeficiency virus research. His work has led to the development of a novel retrovirus, which has implications for detecting antibodies associated with immunodeficiency diseases.

Latest Patents

Zekeng holds a patent for a retrovirus from the HIV group, designated MVP-2901/94. This patent discloses a novel immunodeficiency virus that has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 95012601. The patent also details the characteristic antigens that can be obtained from the virus, which are useful for detecting antibodies against retroviruses linked to immunodeficiency diseases. Additionally, it includes partial DNA and amino acid sequences of the virus.

Career Highlights

Zekeng is associated with Behringwerke Aktiengesellschaft, where he has been involved in groundbreaking research. His work has contributed to advancements in the understanding and detection of retroviruses. His innovative approach has positioned him as a key figure in the field of virology.

Collaborations

Zekeng has collaborated with notable colleagues, including Hans-Peter Hauser and Stefan Knapp. These collaborations have further enhanced the research and development of retroviral studies.

Conclusion

Leopold Achengui Zekeng's contributions to retroviral research have been significant, particularly with his patent MVP-2901/94. His work continues to influence the field of immunodeficiency diseases and highlights the importance of innovation in medical research.